The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, 3-arm, open-label, phase IIa clinical trial to evaluate the safety and efficacy of tanibirumab (VEGFR2 mAb), in patients with recurrent glioblastoma (GBM).
 
Lawrence Cher
Research Funding - PharmAbcine (Inst)
 
Anna K. Nowak
Consulting or Advisory Role - Aduro Biotech; AstraZeneca; Bayer; Boehringer Ingelheim; Epizyme; Morphotek; Roche; Sellas Life Sciences; Trizell
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca
 
George Iatropoulos
Travel, Accommodations, Expenses - MSD Oncology
 
Weon Sup Lee
Employment - PharmAbcine
Leadership - PharmAbcine
Stock and Other Ownership Interests - PharmAbcine
Patents, Royalties, Other Intellectual Property - PharmAbcine
 
Seon Young Lee
Employment - PharmAbcine
Stock and Other Ownership Interests - PharmAbcine
 
Sang Ryeol Shim
Employment - PharmAbcine
Stock and Other Ownership Interests - PharmAbcine
Patents, Royalties, Other Intellectual Property - PharmAbcine
 
Jin San Yoo
Employment - PharmAbcine
Leadership - PharmAbcine
Stock and Other Ownership Interests - PharmAbcine
Patents, Royalties, Other Intellectual Property - PharmAbcine